April 2026

Immunovant’s Batoclimab Fails Phase 3 Trial for Thyroid Eye Disease The landscape for treating Thyroid Eye Disease (TED), a painful and vision-threatening autoimmune condition, has seen significant innovation in recent years. However, the path forward is not without its setbacks. In a significant development, Immunovant Inc. has announced that its lead investigational drug, batoclimab, did […]

Protect Your Vision: Essential Eye Health Tips for Prevention of Blindness Week Every year, Prevention of Blindness Week serves as a crucial reminder of a startling fact: up to 80% of all vision impairment is avoidable. From simple lifestyle adjustments to proactive medical care, the power to protect our sight lies largely in our own

Immunovant’s Eye Disease Drug Fails Pivotal Phase 3 Trial In a significant setback for patients and the biotech company, Immunovant has announced that its investigational drug for thyroid eye disease (TED) failed to meet its primary endpoint in a crucial Phase 3 clinical trial. The news, released on April 2, 2026, sent shockwaves through the

Sight Sciences to Showcase Glaucoma and Dry Eye Innovations at ASCRS 2026 The landscape of ophthalmic care is poised for a significant update as Sight Sciences, Inc. prepares to take center stage at the upcoming 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting. The company has announced that its portfolio of interventional

Marine Animal Virus Triggers Mysterious Human Eye Infections In a startling discovery that blurs the lines between marine biology and human medicine, scientists have identified a virus common in marine animals as the culprit behind a series of mysterious and severe eye infections in people. This finding, reported by New Scientist, reveals a previously unknown

AI Eye Exams Predict Heart Disease Risk in Routine Checkups For decades, the routine eye exam has been a window to the soul of our vision health. But what if that same quick, non-invasive look could also reveal the secrets of your heart? Groundbreaking new research suggests that artificial intelligence (AI), trained to analyze scans